Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA OKs Roche's HIV-1 test for plasma:

This article was originally published in Clinica

Executive Summary

The US FDA has approved Roche Diagnostics' Cobas AmpliScreen HIV-1 test v1.5 for use as a qualitative in vitro test for the direct detection of HIV-1 in both source plasma and organ donors. The test has already been approved and is in use in the US and other countries for screening whole blood donations. Bayer Healthcare's Biological Products Division (Bayer BP) supplied much of the data required for Roche's submission to the FDA. Bayer BP received simultaneous approval from the FDA to perform in-house nucleic acid testing for HIV-1 in plasma donations using Roche's test with pools of 96 test samples.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057503

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel